These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1390585)
1. Redirected targeting of LDL to human monocyte Fc gamma receptors with bispecific antibodies. Morganelli PM; Kitzmiller TJ; Hemmer R; Fanger MW Arterioscler Thromb; 1992 Oct; 12(10):1131-8. PubMed ID: 1390585 [TBL] [Abstract][Full Text] [Related]
2. Enhanced metabolism of LDL aggregates mediated by specific human monocyte IgG Fc receptors. Morganelli PM; Rogers RA; Kitzmiller TJ; Bergeron A J Lipid Res; 1995 Apr; 36(4):714-24. PubMed ID: 7616118 [TBL] [Abstract][Full Text] [Related]
3. Targeting lipoproteins to Fc gamma receptors with bispecific antibodies. Morganelli PM J Hematother; 1995 Oct; 4(5):457-61. PubMed ID: 8581385 [TBL] [Abstract][Full Text] [Related]
4. Evidence that human Fc gamma receptor IIA (CD32) subtypes are not receptors for oxidized LDL. Morganelli PM; Groveman DS; Pfeiffer JR Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3248-54. PubMed ID: 9409319 [TBL] [Abstract][Full Text] [Related]
5. Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36. Kapinsky M; Torzewski M; Büchler C; Duong CQ; Rothe G; Schmitz G Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1004-10. PubMed ID: 11397711 [TBL] [Abstract][Full Text] [Related]
6. The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor. Lopes-Virella MF; Binzafar N; Rackley S; Takei A; La Via M; Virella G Atherosclerosis; 1997 Dec; 135(2):161-70. PubMed ID: 9430365 [TBL] [Abstract][Full Text] [Related]
7. Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies. Lopes-Virella MF; Griffith RL; Shunk KA; Virella GT Arterioscler Thromb; 1991; 11(5):1356-67. PubMed ID: 1911721 [TBL] [Abstract][Full Text] [Related]
8. Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including the Fc gamma R. Connor RI; Dinces NB; Howell AL; Romet-Lemonne JL; Pasquali JL; Fanger MW Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9593-7. PubMed ID: 1835086 [TBL] [Abstract][Full Text] [Related]
9. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32). Ball ED; Guyre PM; Mills L; Fisher J; Dinces NB; Fanger MW J Hematother; 1992; 1(1):85-94. PubMed ID: 1365020 [TBL] [Abstract][Full Text] [Related]
10. Human intravenous immunoglobulin (hIVIG) inhibits anti-CD32 antibody binding to canine DH82 cells and canine monocytes in vitro. Sibley TA; Miller MM; Fogle JE Vet Immunol Immunopathol; 2013 Feb; 151(3-4):229-34. PubMed ID: 23276750 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors. Greenman J; Tutt AL; George AJ; Pulford KA; Stevenson GT; Glennie MJ Mol Immunol; 1991 Nov; 28(11):1243-54. PubMed ID: 1835758 [TBL] [Abstract][Full Text] [Related]
12. Targeting HIV-1 to Fc gamma R on human phagocytes via bispecific antibodies reduces infectivity of HIV-1 to T cells. Howell AL; Guyre PM; You K; Fanger MW J Leukoc Biol; 1994 Mar; 55(3):385-91. PubMed ID: 8120455 [TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors. Mady BJ; Erbe DV; Kurane I; Fanger MW; Ennis FA J Immunol; 1991 Nov; 147(9):3139-44. PubMed ID: 1680925 [TBL] [Abstract][Full Text] [Related]
14. Oxidized LDL immune complexes induce release of sphingosine kinase in human U937 monocytic cells. Hammad SM; Taha TA; Nareika A; Johnson KR; Lopes-Virella MF; Obeid LM Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):126-40. PubMed ID: 16516816 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation. Klimov AN; Denisenko AD; Popov AV; Nagornev VA; Pleskov VM; Vinogradov AG; Denisenko TV; Magracheva EYa ; Kheifes GM; Kuznetzov AS Atherosclerosis; 1985 Dec; 58(1-3):1-15. PubMed ID: 4091875 [TBL] [Abstract][Full Text] [Related]
16. T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex. Ceuppens JL; Bloemmen FJ; Van Wauwe JP J Immunol; 1985 Dec; 135(6):3882-6. PubMed ID: 2933454 [TBL] [Abstract][Full Text] [Related]
17. Immune complexes of LDL induce atherogenic responses in human monocytic cells. Kiener PA; Rankin BM; Davis PM; Yocum SA; Warr GA; Grove RI Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):990-9. PubMed ID: 7600130 [TBL] [Abstract][Full Text] [Related]
18. Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation. Holvoet P; Perez G; Bernar H; Brouwers E; Vanloo B; Rosseneu M; Collen D J Clin Invest; 1994 Jan; 93(1):89-98. PubMed ID: 8282826 [TBL] [Abstract][Full Text] [Related]
19. Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein. Keidar S; Brook GJ; Rosenblat M; Fuhrman B; Dankner G; Aviram M Arterioscler Thromb; 1992 Apr; 12(4):484-93. PubMed ID: 1373074 [TBL] [Abstract][Full Text] [Related]
20. Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics. Asano R; Shimomura I; Konno S; Ito A; Masakari Y; Orimo R; Taki S; Arai K; Ogata H; Okada M; Furumoto S; Onitsuka M; Omasa T; Hayashi H; Katayose Y; Unno M; Kudo T; Umetsu M; Kumagai I MAbs; 2014; 6(5):1243-54. PubMed ID: 25517309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]